Arrowhead Prepays $400 Million Credit Facility at $68 Million Discount
Arrowhead Pharmaceuticals prepaid its $400 million credit facility at a $68 million discount to the contractual minimum repayment.
Related stories
Analysts Raise Estée Lauder Price Targets After Q1 Results
Several analysts raised price targets on Estée Lauder after its fiscal first-quarter results. Shares rose in premarket trading, and the company outlined financial ambitions through
M impact | EQUITY | Nov 04, 2026, 01:19 PM UTC
Vishay Swings to Fiscal Q3 Adjusted Earnings, Revenue Rises; Sets Q4 Guidance
Vishay Intertechnology reported a swing to adjusted earnings for fiscal Q3, higher revenue and initiated fiscal Q4 guidance.
M impact | EQUITY | Nov 04, 2026, 01:19 PM UTC
Eagle Materials Publishes Fiscal Q2 2027 Earnings Presentation
M impact | EQUITY | Nov 04, 2026, 01:19 PM UTC
Scotts Miracle-Gro Q4 Adjusted Loss Widens as Sales Fall, Issues FY2027 Guidance
Scotts Miracle-Gro reported a wider adjusted loss and lower net sales for fiscal Q4 and issued fiscal 2027 guidance.
M impact | EQUITY | Nov 04, 2026, 01:18 PM UTC
Booking Holdings shares rise 4.7% premarket after Q3 results
M impact | EQUITY | Nov 04, 2026, 01:18 PM UTC
ZenaTech Wins Nearly USD 1 Million in Solar Survey Contracts
ZenaTech won solar survey contracts for a US utility valued at nearly USD 1 million.
M impact | EQUITY | Nov 04, 2026, 01:18 PM UTC